[PDF] Top 20 Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival
Has 10000 "Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival" found on our website. Below are the top 20 most common "Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival".
Expression of epidermal growth factor receptor (EGFR) in cholangiocarcinomas: predictive factors and survival
... treatment and histological diagnosis of ...history of smoking or alcoholism, presence of gallstones, family history for neoplasia, histological type, tumor staging and survival ... See full document
9
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
... noted in log-rank test. (p = 0.074) It needs more studies to prove if lack of significance in MBR on OS were due to small study popu- lation or a true negative ... See full document
13
Braz. Dent. J. vol.23 número4
... aim of this study was to assess the immunohistochemical expression of p63 protein, epidermal growth factor receptor (EGFR) and Notch-1 in the epithelial ... See full document
7
The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes.
... secretion of IL-1alpha and IL-1beta by the keratinocytes infected with ...caspase-1 and ASC. In contrast to protein secretion, ...induction of IL-1alpha and IL- 1beta was not ... See full document
14
Androgen receptor expression in triple-negative breast cancer
... binding of epidermal growth factor (EGF), through tyrosine-kinase ...described in different tumors, especially in the central nervous system, lung and stomach ...protein ... See full document
80
PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
... sion and mutation of EGFR often happen in most ...50%–70% of lung cancer, colon cancer and breast cancer have high expression of EGFR ...over-expression of ... See full document
11
Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
... type of breast cancer accounting for 0.2–5% of all invasive mammary carcinomas ...group of neoplasms characterized by differentiation of the neoplastic epithelium into squamous cells ... See full document
13
Int. braz j urol. vol.36 número3
... made in the integration of new biologically- targeted agents in the treatment of ...20% of breast cancer patients have over-expression or ampliication of HER2/neu ...used ... See full document
10
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
... oligoprogression), in which the central nervous system (CNS) or other extra-CNS sites may be the main locations of progression ...(64). In sites such as the brain and bone, local therapy ... See full document
11
Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells.
... gefitinib and erlotinib did not induce caspase-3 activation when an increase in CHOP was ...CHOP expression level can actually beget apoptosis in cells ...induction of CHOP by gefitinib ... See full document
14
Systems biology modeling reveals a possible mechanism of the tumor cell death upon oncogene inactivation in EGFR addicted cancers.
... concept of ‘‘oncogene addiction’’ and many hypotheses rationalizing it, there is still a lack of detailed understanding to the precise molecular mechanism underlying oncogene ...addiction. In ... See full document
12
Clinics vol.67 número5
... Epidermal growth factor receptor (EGFR) is critically involved in NSCLC pathogenesis and has recently emerged as an important target for molecular ...gefitinib and ... See full document
6
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
... Epidermal growth factor receptor (EGFR), member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating ... See full document
22
Expression, mutation and copy number analysis of platelet derived growth factor receptor A
... levels of PDGFA in gliomas (Maxwell et al, 1990; Mapstone, 1991; Hermanson et al, 1992; Di Rocco et al, ...paucity of data on prevalence of PDGFA protein expression in primary ... See full document
10
A novel classification of lung cancer into molecular subtypes.
... dysregulation of mesenchy- mal-epithelial transition factor receptor tyrosine kinase (noted as c- ...membrane receptor known as hepatocyte growth factor receptor (HGFR) ... See full document
11
J. Bras. Patol. Med. Lab. vol.51 número5
... carcinoma of no special type (NST) is characterized by great morphological heterogeneity, and accounts for about 70%-80% of malignant breast ...prognostic factors are tumor size, degree ... See full document
6
Avaliação dos marcadores TGF-β1 e TGF-βII em carcinomas mamários localmente avançados e sua associação com fatores clínico-patológicos
... cases and 460,000 deaths per ...changes in several molecular signalling pathways. Both the predictive and prognostic markers are important for making therapeutic ...decisions. In the ... See full document
82
Arq Bras Endocrinol Metab vol.51 número4
... maturation and stability of a variety of proteins, many of which are crucial in oncogenesis, including epidermal growth factor receptor (EGF-R), Her-2, AKT, ... See full document
13
Clinics vol.67 número11
... al. in a recent issue of your esteemed journal with great interest ...role of epidermal growth factor (EGF) and its receptor (EGFR) in the personaliza- tion ... See full document
1
LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
... Gene expression analysis was performed in untreated pMSCs and pMSCs treated with 1 or 10 μg/mL LL-37 for 2 ...recovered and submitted to ribo- nucleic acid (RNA) extraction using the RNEasy ... See full document
11
temas relacionados